Abstract:
The use of vascular access devices (VAD) is common in healthcare provision but there is a significant risk of acquiring an infection. Central venous catheters (CVC) are associated with the highest risk of intravenous catheter-related bloodstream infection (CRBSI).
[ctt tweet=”ReTweet if useful… Reducing bloodstream infection with a chlorhexidine gel IV dressing http://ctt.ec/Qee9a+ @ivteam #ivteam” coverup=”Qee9a”]
3M™ Tegaderm™ CHG IV dressing is a semi-permeable transparent adhesive dressing with an integrated gel pad containing chlorhexidine gluconate 2%. This product was reviewed by the National Institute for Health and Care Excellence (NICE) in 2015, recommending that Tegaderm CHG could be used for CVC and arterial line dressings in high-dependency and intensive-care settings. This article discusses issues around CRBSI, interventions to reduce the risk of CRBSI, and the use of Tegaderm CHG dressing.
Reference:
Jeanes, A. and Bitmead, J. (2015) Reducing bloodstream infection with a chlorhexidine gel IV dressing. British Journal of Nursing. 24(Sup19), p.S14–S19.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]